drug
fexinidazole
Marketedupdated 3mo agoby Sanofi-Aventis US LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying fexinidazole
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 16, 2028
~1.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
FDA exclusivities (2)
- Jul 16, 2028ODE-359Orphan Drug (7y)1.9y
- Jul 16, 2026NCENew Chemical Entity (5y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that